KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 117 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $1,236,000 | -12.0% | 302,157 | 0.0% | 0.15% | -20.0% |
| Q4 2017 | $1,405,000 | -50.5% | 302,157 | -24.5% | 0.19% | -47.7% |
| Q3 2017 | $2,840,000 | -7.6% | 400,000 | -5.9% | 0.36% | -17.7% |
| Q2 2017 | $3,074,000 | +17.4% | 425,111 | 0.0% | 0.44% | +6.3% |
| Q1 2017 | $2,619,000 | +5.1% | 425,111 | 0.0% | 0.42% | -13.2% |
| Q4 2016 | $2,491,000 | -99.9% | 425,111 | -15.0% | 0.48% | +13.3% |
| Q3 2016 | $2,655,589,000 | +89013.7% | 500,111 | +11.1% | 0.42% | -20.2% |
| Q2 2016 | $2,980,000 | -32.8% | 450,111 | -52.6% | 0.53% | -40.0% |
| Q1 2016 | $4,437,000 | -28.7% | 950,000 | -23.0% | 0.88% | -6.4% |
| Q4 2015 | $6,227,000 | +13.2% | 1,233,000 | -21.1% | 0.94% | +7.3% |
| Q3 2015 | $5,502,000 | +3.2% | 1,563,000 | +192.7% | 0.88% | +37.0% |
| Q2 2015 | $5,329,000 | +40.9% | 534,000 | +79.8% | 0.64% | +0.3% |
| Q1 2015 | $3,781,000 | +195.6% | 297,000 | +228.5% | 0.64% | +72.0% |
| Q4 2014 | $1,279,000 | -31.6% | 90,424 | -33.5% | 0.37% | -32.3% |
| Q3 2014 | $1,870,000 | -49.3% | 136,000 | -43.3% | 0.55% | -50.0% |
| Q2 2014 | $3,691,000 | -18.4% | 240,000 | -9.5% | 1.10% | -19.3% |
| Q1 2014 | $4,521,000 | -12.7% | 265,325 | -33.7% | 1.36% | -33.0% |
| Q4 2013 | $5,180,000 | – | 400,000 | – | 2.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $3 | 0.00% |